Girindus is a multi-national company with operating sites in both Germany and the US. In Halle-Kuensebeck, Germany, Girindus operates a commercial-scale FDA-inspected synthesis facility. In Cincinnati, Ohio Girindus operates a 52,000 sq-ft facility which is focused on pre-clinical and early phase clinical cGMP APIs and commercial scale manufacture of cGMP oligonucleotides. Girindus has an outstanding regulatory track record and our last four FDA inspections have resulted in zero form 483s.
